Millennium Management LLC Lowers Stock Position in National Research Co. (NASDAQ:NRC)

Millennium Management LLC trimmed its holdings in shares of National Research Co. (NASDAQ:NRC - Free Report) by 64.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 81,961 shares of the company's stock after selling 149,637 shares during the period. Millennium Management LLC owned approximately 0.35% of National Research worth $1,446,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in NRC. SG Americas Securities LLC lifted its stake in shares of National Research by 35.0% in the 4th quarter. SG Americas Securities LLC now owns 7,298 shares of the company's stock valued at $129,000 after purchasing an additional 1,893 shares during the period. Principal Financial Group Inc. lifted its stake in shares of National Research by 10.7% in the 4th quarter. Principal Financial Group Inc. now owns 12,018 shares of the company's stock valued at $212,000 after purchasing an additional 1,161 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of National Research by 88.5% in the 4th quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company's stock valued at $3,832,000 after purchasing an additional 101,957 shares during the period. Proficio Capital Partners LLC acquired a new position in National Research during the fourth quarter worth $283,000. Finally, Norden Group LLC acquired a new position in National Research during the fourth quarter worth $182,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Price Performance

NASDAQ:NRC traded up $0.28 during trading hours on Thursday, reaching $14.37. 58,082 shares of the company were exchanged, compared to its average volume of 95,904. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. The stock's 50-day moving average is $12.44 and its 200-day moving average is $15.42. The firm has a market cap of $327.42 million, a PE ratio of 13.69 and a beta of 0.34. National Research Co. has a twelve month low of $9.76 and a twelve month high of $27.94.

National Research (NASDAQ:NRC - Get Free Report) last posted its quarterly earnings data on Monday, April 28th. The company reported $0.25 earnings per share for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%. The company had revenue of $33.55 million during the quarter.

National Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.34%. The ex-dividend date of this dividend is Friday, June 27th. National Research's payout ratio is 46.60%.

Insider Transactions at National Research

In other National Research news, major shareholder Patrick E. Beans bought 2,500 shares of the company's stock in a transaction dated Monday, May 12th. The stock was acquired at an average price of $13.59 per share, with a total value of $33,975.00. Following the completion of the acquisition, the insider now directly owns 35,003 shares of the company's stock, valued at $475,690.77. This represents a 7.69% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 8.10% of the company's stock.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.